![Isabel Aznarez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isabel Aznarez
Oprichter bij
STOKE THERAPEUTICS, INC.
Profiel
Dr. Isabel Aznarez is a Chief Technology Officer at Stoke Therapeutics, Inc. She is on the Board of Directors at Oligonucleotide Therapeutics Society, Inc. She received her undergraduate degree from Universidad De La Republica Uruguay and a doctorate degree from the University of Toronto.
Actieve functies van Isabel Aznarez
| Bedrijven | Functie | Begin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Oprichter | 01-06-2014 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Directeur/Bestuurslid | 01-01-2019 |
Opleiding van Isabel Aznarez
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
83
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Universidad De La Republica Uruguay
 Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
